Privi Speciality Chemicals gets USFDA certificate for camphor product
Regulatory

Privi Speciality Chemicals gets USFDA certificate for camphor product

The company can now expand its business horizon into the area of pharmaceutical applications in the USA

  • By ICN Bureau | October 11, 2024

Privi Speciality Chemicals Limited has received "Certificate of API (Active Pharmaceuticals lngredient) Product Listing" and "Certificate of Registration" for its camphor product from U.S. Food and Drug Administration (USFDA).

Having received the said registration, the company can now expand its business horizon into the area of pharmaceutical applications in the USA.

The company has already received license for manufacture, sale, and distribution of camphor (Form 25) from Food and Drugs Administration, Maharashtra state which enables it to sell camphor to the Indian pharmaceutical companies.

Register Now to Attend Gujarat Chem & Petchem Conference 2025 on May 8-9th 2025, at Hyatt Place, Bharuch

Upcoming E-conferences

Gujarat Chem & Petchem Conference 2025

May 08, 2025

Other Related stories

Startups

Chemical

Petrochemical

Energy

Digitization